NOX-D20

a complement factor C5a antagonist

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

1.	Sepsis (Septicemia) 12/01/2013 - "Our study suggests NOX-D20 as a new therapeutic candidate for the treatment of sepsis." 12/01/2013 - "In the model of polymicrobial sepsis induced by cecal ligation and puncture (CLP), NOX-D20 attenuated inflammation and organ damage, prevented the breakdown of the vascular endothelial barrier, and improved survival. "
2.	Inflammation (Inflammations) 12/01/2013 - "In the model of polymicrobial sepsis induced by cecal ligation and puncture (CLP), NOX-D20 attenuated inflammation and organ damage, prevented the breakdown of the vascular endothelial barrier, and improved survival. "